LTR PHARMA FPO [LTP]

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.ltrpharma.com

Country

Australia

Exchange

ASX

Brisbane, Australia

LTR Pharma Limited, a clinical-stage pharmaceutical company provides the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. Incorporated in 2020, the company is headquartered in Brisbane, Australia.

Key Stats

52-Week Range

A$0.31A$0.81

Beta2.22

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.05

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.